ExhibitNerve Tissue Processing Agreement • March 1st, 2017
Contract Type FiledMarch 1st, 2017*10.4.3 Third Amendment to Amended and Restated Nerve Tissue Processing Agreement, dated as of March 12, 2012, by and between AxoGen Corporation and LifeNet Health (incorporated by reference to Exhibit 10.4.3 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, filed on March 15, 2012).